1. Home
  2. KRRO vs VBNK Comparison

KRRO vs VBNK Comparison

Compare KRRO & VBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • VBNK
  • Stock Information
  • Founded
  • KRRO 2014
  • VBNK 1980
  • Country
  • KRRO United States
  • VBNK Canada
  • Employees
  • KRRO N/A
  • VBNK N/A
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • VBNK Commercial Banks
  • Sector
  • KRRO Health Care
  • VBNK Finance
  • Exchange
  • KRRO Nasdaq
  • VBNK Nasdaq
  • Market Cap
  • KRRO 320.9M
  • VBNK 338.3M
  • IPO Year
  • KRRO 2019
  • VBNK 2021
  • Fundamental
  • Price
  • KRRO $33.59
  • VBNK $13.30
  • Analyst Decision
  • KRRO Strong Buy
  • VBNK Strong Buy
  • Analyst Count
  • KRRO 5
  • VBNK 3
  • Target Price
  • KRRO $123.75
  • VBNK $16.67
  • AVG Volume (30 Days)
  • KRRO 65.7K
  • VBNK 33.6K
  • Earning Date
  • KRRO 11-27-2024
  • VBNK 09-05-2024
  • Dividend Yield
  • KRRO N/A
  • VBNK 0.56%
  • EPS Growth
  • KRRO N/A
  • VBNK 33.56
  • EPS
  • KRRO N/A
  • VBNK 1.28
  • Revenue
  • KRRO N/A
  • VBNK $82,396,676.00
  • Revenue This Year
  • KRRO N/A
  • VBNK N/A
  • Revenue Next Year
  • KRRO N/A
  • VBNK $22.69
  • P/E Ratio
  • KRRO N/A
  • VBNK $10.43
  • Revenue Growth
  • KRRO N/A
  • VBNK 10.81
  • 52 Week Low
  • KRRO $9.15
  • VBNK $7.24
  • 52 Week High
  • KRRO $97.91
  • VBNK $14.22
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 39.03
  • VBNK 56.57
  • Support Level
  • KRRO $31.62
  • VBNK $13.00
  • Resistance Level
  • KRRO $36.69
  • VBNK $13.50
  • Average True Range (ATR)
  • KRRO 2.75
  • VBNK 0.34
  • MACD
  • KRRO -0.26
  • VBNK -0.04
  • Stochastic Oscillator
  • KRRO 23.71
  • VBNK 55.91

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About VBNK VersaBank

VersaBank is a Canadian Schedule I chartered bank with a difference. VersaBank became the world's first digital financial institution when it adopted its highly efficient business-to-business model using its proprietary state-of-the-art financial technology to profitably address underserved segments of the Canadian banking market in the pursuit of superior net interest margins, while mitigating risk. VersaBank obtains all of its deposits and provides the majority of its loans and leases electronically, with innovative deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, VersaBank established a wholly-owned, subsidiary.

Share on Social Networks: